Linda Watkins
Concepts (944)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperalgesia | 69 | 2023 | 107 | 11.600 |
Why?
| Neuralgia | 39 | 2023 | 122 | 11.170 |
Why?
| Toll-Like Receptor 4 | 46 | 2023 | 286 | 8.660 |
Why?
| Pain | 58 | 2021 | 710 | 7.740 |
Why?
| Microglia | 53 | 2022 | 202 | 7.110 |
Why?
| Rats, Sprague-Dawley | 234 | 2023 | 2209 | 6.910 |
Why?
| Spinal Cord | 48 | 2023 | 347 | 6.270 |
Why?
| Morphine | 41 | 2020 | 122 | 6.200 |
Why?
| Rats | 275 | 2023 | 4943 | 6.140 |
Why?
| Neuroglia | 36 | 2015 | 150 | 4.670 |
Why?
| Analgesics, Opioid | 38 | 2019 | 773 | 4.660 |
Why?
| Neuroimmunomodulation | 33 | 2019 | 70 | 3.670 |
Why?
| Animals | 350 | 2023 | 31761 | 3.560 |
Why?
| Cytokines | 51 | 2021 | 1843 | 3.460 |
Why?
| Interleukin-10 | 22 | 2023 | 296 | 3.420 |
Why?
| Spinal Cord Injuries | 9 | 2021 | 172 | 3.210 |
Why?
| Interleukin-1beta | 33 | 2023 | 370 | 3.160 |
Why?
| Stress, Psychological | 58 | 2020 | 944 | 3.130 |
Why?
| Inflammation | 50 | 2020 | 2481 | 2.960 |
Why?
| Interleukin-1 | 48 | 2011 | 966 | 2.930 |
Why?
| Behavior, Animal | 54 | 2020 | 460 | 2.760 |
Why?
| Sciatic Neuropathy | 13 | 2023 | 24 | 2.740 |
Why?
| Lipopolysaccharides | 50 | 2023 | 812 | 2.650 |
Why?
| Lymphocyte Antigen 96 | 12 | 2019 | 24 | 2.650 |
Why?
| Hippocampus | 50 | 2020 | 695 | 2.600 |
Why?
| Injections, Spinal | 39 | 2018 | 101 | 2.490 |
Why?
| Central Nervous System | 13 | 2018 | 237 | 2.470 |
Why?
| Pain Threshold | 23 | 2019 | 67 | 2.440 |
Why?
| Signal Transduction | 41 | 2019 | 4521 | 2.310 |
Why?
| Narcotic Antagonists | 20 | 2020 | 136 | 2.270 |
Why?
| Stress, Physiological | 43 | 2017 | 379 | 2.190 |
Why?
| Inflammasomes | 9 | 2023 | 115 | 2.150 |
Why?
| Corticosterone | 32 | 2019 | 211 | 2.150 |
Why?
| Pain Measurement | 36 | 2019 | 445 | 2.050 |
Why?
| Male | 278 | 2023 | 55558 | 2.020 |
Why?
| Naltrexone | 19 | 2023 | 83 | 1.970 |
Why?
| Inflammation Mediators | 16 | 2020 | 476 | 1.970 |
Why?
| Analgesia | 13 | 2015 | 82 | 1.960 |
Why?
| Chronic Pain | 7 | 2023 | 211 | 1.950 |
Why?
| Encephalomyelitis, Autoimmune, Experimental | 5 | 2021 | 51 | 1.950 |
Why?
| Adenosine A2 Receptor Agonists | 4 | 2018 | 19 | 1.850 |
Why?
| Raphe Nuclei | 28 | 2014 | 110 | 1.780 |
Why?
| HIV Envelope Protein gp120 | 12 | 2010 | 56 | 1.750 |
Why?
| Genetic Therapy | 15 | 2023 | 257 | 1.750 |
Why?
| Disease Models, Animal | 44 | 2021 | 3542 | 1.710 |
Why?
| Vagus Nerve | 16 | 2001 | 79 | 1.680 |
Why?
| Fear | 32 | 2020 | 292 | 1.650 |
Why?
| Naloxone | 16 | 2019 | 97 | 1.590 |
Why?
| Prefrontal Cortex | 20 | 2018 | 261 | 1.550 |
Why?
| HMGB1 Protein | 12 | 2019 | 48 | 1.500 |
Why?
| Brain | 32 | 2019 | 2369 | 1.400 |
Why?
| Peripheral Nervous System Diseases | 9 | 2012 | 121 | 1.400 |
Why?
| Helplessness, Learned | 19 | 2012 | 61 | 1.380 |
Why?
| Sciatic Nerve | 10 | 2023 | 56 | 1.380 |
Why?
| Encephalitis | 10 | 2018 | 127 | 1.360 |
Why?
| Minocycline | 8 | 2017 | 26 | 1.360 |
Why?
| Neurons | 25 | 2022 | 1280 | 1.300 |
Why?
| Astrocytes | 10 | 2019 | 162 | 1.290 |
Why?
| Receptors, Interleukin-1 | 17 | 2016 | 227 | 1.270 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 11 | 2023 | 144 | 1.260 |
Why?
| Electroshock | 59 | 2018 | 134 | 1.230 |
Why?
| Pain Management | 8 | 2021 | 289 | 1.230 |
Why?
| Glucocorticoids | 17 | 2019 | 532 | 1.230 |
Why?
| Serotonin | 32 | 2020 | 291 | 1.220 |
Why?
| Piperidines | 5 | 2018 | 161 | 1.220 |
Why?
| Conditioning, Classical | 11 | 2020 | 87 | 1.210 |
Why?
| Tumor Necrosis Factor-alpha | 26 | 2019 | 1134 | 1.200 |
Why?
| Peripheral Nerve Injuries | 5 | 2023 | 32 | 1.190 |
Why?
| Toll-Like Receptor 2 | 7 | 2021 | 109 | 1.160 |
Why?
| Immune System | 8 | 2012 | 173 | 1.140 |
Why?
| Nucleus Accumbens | 9 | 2019 | 124 | 1.130 |
Why?
| Central Nervous System Stimulants | 6 | 2019 | 139 | 1.110 |
Why?
| Escape Reaction | 23 | 2014 | 58 | 1.110 |
Why?
| Memory Disorders | 15 | 2020 | 154 | 1.080 |
Why?
| Circadian Rhythm | 7 | 2019 | 355 | 1.020 |
Why?
| Osteoarthritis | 2 | 2020 | 171 | 1.010 |
Why?
| Escherichia coli Infections | 15 | 2014 | 100 | 0.980 |
Why?
| MicroRNAs | 3 | 2021 | 601 | 0.980 |
Why?
| Dose-Response Relationship, Drug | 39 | 2023 | 1846 | 0.980 |
Why?
| RNA, Messenger | 26 | 2017 | 2557 | 0.970 |
Why?
| Dopamine | 8 | 2019 | 235 | 0.950 |
Why?
| Ventral Tegmental Area | 4 | 2019 | 45 | 0.920 |
Why?
| Conditioning, Operant | 12 | 2017 | 97 | 0.920 |
Why?
| Glucuronides | 2 | 2014 | 12 | 0.910 |
Why?
| Alarmins | 5 | 2018 | 25 | 0.900 |
Why?
| Vagotomy | 15 | 2001 | 34 | 0.900 |
Why?
| Aging | 16 | 2021 | 1620 | 0.900 |
Why?
| Posterior Horn Cells | 2 | 2019 | 4 | 0.890 |
Why?
| Pyridines | 7 | 2017 | 425 | 0.870 |
Why?
| Ganglia, Spinal | 5 | 2016 | 41 | 0.870 |
Why?
| Narcotics | 8 | 2014 | 44 | 0.860 |
Why?
| Fever | 10 | 2011 | 279 | 0.860 |
Why?
| Motor Activity | 21 | 2023 | 640 | 0.860 |
Why?
| Cocaine | 5 | 2023 | 153 | 0.850 |
Why?
| Physical Stimulation | 13 | 2014 | 77 | 0.840 |
Why?
| Morphine Derivatives | 2 | 2014 | 13 | 0.830 |
Why?
| Toll-Like Receptors | 6 | 2017 | 166 | 0.820 |
Why?
| Analysis of Variance | 27 | 2018 | 1226 | 0.810 |
Why?
| Chemokines, CX3C | 4 | 2005 | 10 | 0.800 |
Why?
| Time Factors | 41 | 2019 | 6124 | 0.790 |
Why?
| Methamphetamine | 3 | 2019 | 51 | 0.780 |
Why?
| Drug Delivery Systems | 4 | 2014 | 296 | 0.780 |
Why?
| Drug Tolerance | 6 | 2017 | 79 | 0.770 |
Why?
| Rats, Inbred F344 | 19 | 2018 | 241 | 0.770 |
Why?
| Plasmids | 8 | 2020 | 345 | 0.760 |
Why?
| Interleukin-6 | 15 | 2014 | 675 | 0.760 |
Why?
| Anxiety | 15 | 2020 | 840 | 0.750 |
Why?
| Sciatica | 6 | 2012 | 8 | 0.750 |
Why?
| Migraine Disorders | 3 | 2017 | 82 | 0.740 |
Why?
| Anti-Inflammatory Agents | 4 | 2018 | 450 | 0.740 |
Why?
| Phenethylamines | 2 | 2018 | 17 | 0.720 |
Why?
| Amygdala | 10 | 2017 | 170 | 0.710 |
Why?
| Nociceptors | 8 | 2006 | 15 | 0.710 |
Why?
| Pain, Intractable | 3 | 2010 | 8 | 0.710 |
Why?
| Nicotinic Agonists | 2 | 2012 | 100 | 0.700 |
Why?
| Arthralgia | 1 | 2020 | 46 | 0.690 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 14 | 2012 | 253 | 0.690 |
Why?
| Gene Expression Regulation | 19 | 2019 | 2321 | 0.670 |
Why?
| Laparotomy | 5 | 2020 | 96 | 0.660 |
Why?
| Synapses | 1 | 2022 | 330 | 0.660 |
Why?
| Reactive Oxygen Species | 2 | 2016 | 536 | 0.660 |
Why?
| Multiple Sclerosis | 4 | 2021 | 380 | 0.650 |
Why?
| Receptors, Nicotinic | 2 | 2012 | 274 | 0.650 |
Why?
| Defecation | 1 | 2019 | 17 | 0.640 |
Why?
| Chronobiology Disorders | 1 | 2018 | 12 | 0.640 |
Why?
| Adenosine | 2 | 2018 | 202 | 0.640 |
Why?
| Sex Characteristics | 5 | 2018 | 635 | 0.640 |
Why?
| Spinal Cord Dorsal Horn | 3 | 2019 | 5 | 0.620 |
Why?
| Macrophages | 11 | 2017 | 1261 | 0.600 |
Why?
| Immunity, Innate | 14 | 2019 | 723 | 0.600 |
Why?
| Neuroprotective Agents | 3 | 2015 | 105 | 0.600 |
Why?
| Ethanol | 5 | 2014 | 548 | 0.590 |
Why?
| Neurons, Afferent | 4 | 2007 | 85 | 0.590 |
Why?
| Humans | 87 | 2023 | 114716 | 0.580 |
Why?
| Membrane Proteins | 5 | 2010 | 1022 | 0.580 |
Why?
| Trigeminal Caudal Nucleus | 1 | 2017 | 1 | 0.570 |
Why?
| Contusions | 1 | 2017 | 19 | 0.570 |
Why?
| Proto-Oncogene Proteins c-fos | 14 | 2018 | 164 | 0.570 |
Why?
| Substance-Related Disorders | 3 | 2015 | 947 | 0.570 |
Why?
| Pain, Postoperative | 1 | 2019 | 191 | 0.570 |
Why?
| Facial Nerve Injuries | 1 | 2016 | 3 | 0.560 |
Why?
| Facial Nerve | 1 | 2016 | 31 | 0.560 |
Why?
| Spinal Injuries | 1 | 2017 | 47 | 0.550 |
Why?
| Reactive Nitrogen Species | 1 | 2016 | 21 | 0.550 |
Why?
| Exercise Movement Techniques | 1 | 2016 | 4 | 0.550 |
Why?
| Reward | 8 | 2015 | 211 | 0.540 |
Why?
| Catheters, Indwelling | 3 | 2012 | 79 | 0.540 |
Why?
| NADPH Oxidases | 1 | 2016 | 120 | 0.540 |
Why?
| Cells, Cultured | 16 | 2020 | 3890 | 0.530 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2018 | 192 | 0.530 |
Why?
| Reaction Time | 16 | 2012 | 375 | 0.530 |
Why?
| Liver | 6 | 2019 | 1631 | 0.520 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 2 | 2014 | 130 | 0.520 |
Why?
| Xanthines | 2 | 2014 | 15 | 0.510 |
Why?
| Catheterization | 6 | 2007 | 160 | 0.510 |
Why?
| Hindlimb | 3 | 2013 | 130 | 0.500 |
Why?
| Excitatory Amino Acid Transporter 2 | 2 | 2016 | 13 | 0.500 |
Why?
| Memory | 9 | 2018 | 209 | 0.500 |
Why?
| Dorsal Raphe Nucleus | 4 | 2020 | 27 | 0.490 |
Why?
| Resilience, Psychological | 3 | 2018 | 96 | 0.490 |
Why?
| Paralysis | 2 | 2015 | 66 | 0.480 |
Why?
| Xenobiotics | 1 | 2015 | 24 | 0.480 |
Why?
| Endotoxins | 5 | 2012 | 204 | 0.480 |
Why?
| T-Lymphocytes | 2 | 2021 | 1745 | 0.480 |
Why?
| Fatigue | 1 | 2016 | 295 | 0.470 |
Why?
| Hot Temperature | 10 | 2009 | 304 | 0.470 |
Why?
| Gliosis | 4 | 2013 | 29 | 0.460 |
Why?
| Microinjections | 16 | 2018 | 77 | 0.450 |
Why?
| Neuropharmacology | 1 | 2013 | 5 | 0.440 |
Why?
| Disease | 4 | 1999 | 85 | 0.430 |
Why?
| Gonadal Steroid Hormones | 1 | 2014 | 124 | 0.430 |
Why?
| Glucuronic Acid | 1 | 2013 | 26 | 0.430 |
Why?
| Quinuclidines | 1 | 2012 | 4 | 0.430 |
Why?
| Chronic Disease | 10 | 2017 | 1590 | 0.420 |
Why?
| Arthritis, Rheumatoid | 1 | 2021 | 1002 | 0.420 |
Why?
| Estradiol | 2 | 2014 | 455 | 0.420 |
Why?
| Myeloid Differentiation Factor 88 | 5 | 2014 | 90 | 0.420 |
Why?
| Mice | 23 | 2021 | 14916 | 0.420 |
Why?
| HSP90 Heat-Shock Proteins | 2 | 2010 | 43 | 0.410 |
Why?
| Allergy and Immunology | 1 | 2013 | 51 | 0.410 |
Why?
| Injections, Intraperitoneal | 16 | 2009 | 100 | 0.410 |
Why?
| Models, Animal | 1 | 2014 | 345 | 0.400 |
Why?
| Exploratory Behavior | 7 | 2018 | 82 | 0.400 |
Why?
| Facial Pain | 1 | 2012 | 11 | 0.400 |
Why?
| Neural Pathways | 12 | 2018 | 258 | 0.400 |
Why?
| Thiophenes | 1 | 2012 | 108 | 0.400 |
Why?
| Hyperesthesia | 3 | 2007 | 7 | 0.390 |
Why?
| Complement System Proteins | 2 | 2005 | 285 | 0.390 |
Why?
| Neuralgia, Postherpetic | 1 | 2012 | 44 | 0.390 |
Why?
| NF-kappa B | 8 | 2019 | 636 | 0.390 |
Why?
| Protein Kinase C | 1 | 2013 | 275 | 0.390 |
Why?
| DNA | 5 | 2023 | 1351 | 0.380 |
Why?
| Animals, Newborn | 14 | 2019 | 777 | 0.380 |
Why?
| Corticotropin-Releasing Hormone | 6 | 2005 | 67 | 0.380 |
Why?
| Brain-Derived Neurotrophic Factor | 6 | 2009 | 106 | 0.380 |
Why?
| Gram-Negative Bacterial Infections | 1 | 2011 | 37 | 0.380 |
Why?
| CD11b Antigen | 6 | 2010 | 57 | 0.370 |
Why?
| Parkinson Disease | 1 | 2014 | 323 | 0.360 |
Why?
| Avoidance Learning | 5 | 2018 | 63 | 0.360 |
Why?
| Drug-Seeking Behavior | 2 | 2023 | 22 | 0.360 |
Why?
| Diet, High-Fat | 3 | 2017 | 225 | 0.360 |
Why?
| Ceftriaxone | 1 | 2010 | 18 | 0.360 |
Why?
| Heterocyclic Compounds, 3-Ring | 1 | 2010 | 28 | 0.350 |
Why?
| Chemokines | 3 | 2021 | 213 | 0.340 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 11 | 2012 | 928 | 0.340 |
Why?
| Female | 34 | 2023 | 59486 | 0.340 |
Why?
| Receptors, Opioid, mu | 6 | 2020 | 52 | 0.340 |
Why?
| Receptor, Adenosine A2A | 1 | 2009 | 20 | 0.340 |
Why?
| Meninges | 2 | 2006 | 29 | 0.340 |
Why?
| Constriction, Pathologic | 4 | 2016 | 208 | 0.330 |
Why?
| Formaldehyde | 6 | 2013 | 46 | 0.330 |
Why?
| Morphinans | 3 | 2015 | 7 | 0.330 |
Why?
| Up-Regulation | 4 | 2013 | 812 | 0.330 |
Why?
| Respiratory Insufficiency | 2 | 2014 | 291 | 0.330 |
Why?
| Self Administration | 5 | 2023 | 123 | 0.330 |
Why?
| Endothelial Cells | 1 | 2014 | 681 | 0.330 |
Why?
| Cell Line | 13 | 2019 | 2639 | 0.320 |
Why?
| Sialoglycoproteins | 8 | 2004 | 158 | 0.320 |
Why?
| Functional Laterality | 7 | 2016 | 197 | 0.320 |
Why?
| Neurotransmitter Agents | 2 | 2006 | 76 | 0.320 |
Why?
| Mice, Inbred BALB C | 7 | 2014 | 1151 | 0.320 |
Why?
| Wakefulness | 1 | 2009 | 128 | 0.310 |
Why?
| Behavior | 3 | 2006 | 92 | 0.310 |
Why?
| Glutamic Acid | 1 | 2010 | 211 | 0.310 |
Why?
| Enzyme-Linked Immunosorbent Assay | 7 | 2012 | 797 | 0.310 |
Why?
| Cerebral Cortex | 4 | 2018 | 380 | 0.310 |
Why?
| Injections, Subcutaneous | 9 | 2012 | 134 | 0.310 |
Why?
| Biomedical Research | 2 | 2013 | 585 | 0.300 |
Why?
| Receptors, Tumor Necrosis Factor | 3 | 2004 | 139 | 0.300 |
Why?
| Receptors, Immunologic | 3 | 2019 | 201 | 0.300 |
Why?
| Face | 1 | 2009 | 168 | 0.300 |
Why?
| Molecular Dynamics Simulation | 3 | 2019 | 201 | 0.300 |
Why?
| Receptors, Opioid | 3 | 2011 | 19 | 0.300 |
Why?
| Microdialysis | 13 | 2012 | 49 | 0.300 |
Why?
| Cognition | 6 | 2018 | 983 | 0.300 |
Why?
| Substance Withdrawal Syndrome | 5 | 2011 | 159 | 0.290 |
Why?
| Receptors, Complement | 2 | 2005 | 111 | 0.290 |
Why?
| Drug Design | 2 | 2010 | 151 | 0.290 |
Why?
| Cues | 8 | 2013 | 300 | 0.290 |
Why?
| Locomotion | 2 | 2018 | 80 | 0.290 |
Why?
| Clozapine | 2 | 2018 | 19 | 0.290 |
Why?
| Constriction | 3 | 2023 | 45 | 0.290 |
Why?
| Hypothalamus | 5 | 2008 | 147 | 0.290 |
Why?
| Alkaline Phosphatase | 3 | 2014 | 143 | 0.280 |
Why?
| Crotalid Venoms | 2 | 2004 | 31 | 0.280 |
Why?
| Drug Administration Schedule | 7 | 2019 | 718 | 0.280 |
Why?
| Phospholipases A | 2 | 2004 | 101 | 0.280 |
Why?
| Nitric Oxide | 7 | 2019 | 824 | 0.280 |
Why?
| Chemokine CX3CL1 | 5 | 2008 | 20 | 0.280 |
Why?
| Mycobacterium | 2 | 2018 | 103 | 0.280 |
Why?
| Neuronal Plasticity | 3 | 2022 | 209 | 0.280 |
Why?
| Corpus Striatum | 3 | 2018 | 125 | 0.270 |
Why?
| Adaptation, Psychological | 2 | 2010 | 547 | 0.270 |
Why?
| Immunocompetence | 1 | 2006 | 40 | 0.270 |
Why?
| Nerve Tissue Proteins | 5 | 2011 | 529 | 0.270 |
Why?
| Transfection | 3 | 2018 | 870 | 0.270 |
Why?
| Limbic System | 3 | 2019 | 43 | 0.270 |
Why?
| Immunohistochemistry | 17 | 2010 | 1635 | 0.270 |
Why?
| Dinoprostone | 4 | 2014 | 184 | 0.270 |
Why?
| Ketamine | 3 | 2018 | 92 | 0.260 |
Why?
| HEK293 Cells | 5 | 2016 | 593 | 0.260 |
Why?
| Citrates | 6 | 2006 | 43 | 0.260 |
Why?
| Hypothalamo-Hypophyseal System | 5 | 2012 | 165 | 0.260 |
Why?
| Extinction, Psychological | 5 | 2023 | 78 | 0.260 |
Why?
| Protein Binding | 9 | 2018 | 1896 | 0.260 |
Why?
| Cisterna Magna | 4 | 2013 | 8 | 0.260 |
Why?
| Paclitaxel | 1 | 2006 | 190 | 0.260 |
Why?
| Freezing Reaction, Cataleptic | 4 | 2013 | 22 | 0.260 |
Why?
| DNA-Binding Proteins | 3 | 2023 | 1314 | 0.260 |
Why?
| Bacterial Infections | 4 | 2009 | 219 | 0.250 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2006 | 181 | 0.250 |
Why?
| Oxycodone | 3 | 2019 | 44 | 0.250 |
Why?
| Analgesics | 5 | 2020 | 158 | 0.250 |
Why?
| Arousal | 6 | 2002 | 152 | 0.240 |
Why?
| Antibodies | 6 | 2018 | 371 | 0.240 |
Why?
| Dependovirus | 1 | 2005 | 52 | 0.240 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 5 | 2013 | 299 | 0.240 |
Why?
| Models, Immunological | 1 | 2005 | 92 | 0.240 |
Why?
| Cyclooxygenase 2 | 4 | 2019 | 164 | 0.240 |
Why?
| Ligation | 3 | 2013 | 75 | 0.240 |
Why?
| Nitric Oxide Synthase | 2 | 2004 | 209 | 0.240 |
Why?
| Models, Neurological | 2 | 2003 | 212 | 0.230 |
Why?
| Receptors, Tumor Necrosis Factor, Type I | 4 | 2008 | 72 | 0.230 |
Why?
| Mice, Knockout | 5 | 2021 | 2582 | 0.230 |
Why?
| Central Nervous System Agents | 1 | 2003 | 5 | 0.230 |
Why?
| Body Fluids | 1 | 2004 | 58 | 0.230 |
Why?
| Brain Mapping | 8 | 2018 | 522 | 0.230 |
Why?
| Glial Fibrillary Acidic Protein | 8 | 2015 | 79 | 0.230 |
Why?
| Antigens, CD | 4 | 2017 | 443 | 0.230 |
Why?
| Gap Junctions | 1 | 2004 | 58 | 0.230 |
Why?
| Cholecystokinin | 4 | 2000 | 15 | 0.230 |
Why?
| Neural Inhibition | 2 | 2010 | 140 | 0.220 |
Why?
| Opioid-Related Disorders | 5 | 2017 | 413 | 0.220 |
Why?
| Cognitive Dysfunction | 2 | 2018 | 273 | 0.220 |
Why?
| Lumbosacral Region | 4 | 2013 | 46 | 0.220 |
Why?
| Carrier Proteins | 5 | 2015 | 696 | 0.220 |
Why?
| Central Nervous System Diseases | 2 | 2017 | 61 | 0.220 |
Why?
| Learning | 7 | 2018 | 351 | 0.220 |
Why?
| Enzyme Inhibitors | 6 | 2007 | 751 | 0.210 |
Why?
| Indoles | 4 | 2013 | 306 | 0.210 |
Why?
| Receptors, Glucocorticoid | 5 | 2016 | 130 | 0.210 |
Why?
| Adrenalectomy | 10 | 2014 | 60 | 0.210 |
Why?
| Mifepristone | 6 | 2019 | 60 | 0.210 |
Why?
| Freund's Adjuvant | 2 | 2013 | 17 | 0.210 |
Why?
| Pituitary Gland | 6 | 2004 | 148 | 0.210 |
Why?
| Receptors, Cytoplasmic and Nuclear | 2 | 2015 | 193 | 0.210 |
Why?
| Norepinephrine | 4 | 2005 | 200 | 0.210 |
Why?
| Injections, Intraventricular | 11 | 2015 | 71 | 0.210 |
Why?
| Synaptic Transmission | 4 | 2010 | 227 | 0.200 |
Why?
| Illness Behavior | 2 | 2014 | 10 | 0.200 |
Why?
| Myelin-Oligodendrocyte Glycoprotein | 2 | 2021 | 44 | 0.200 |
Why?
| Brain Chemistry | 3 | 2004 | 116 | 0.200 |
Why?
| Gene Expression | 8 | 2020 | 1420 | 0.200 |
Why?
| Fibroblast Growth Factor 2 | 3 | 2007 | 83 | 0.200 |
Why?
| Spleen | 7 | 2014 | 484 | 0.200 |
Why?
| Random Allocation | 6 | 2016 | 335 | 0.200 |
Why?
| Affect | 3 | 2018 | 245 | 0.200 |
Why?
| p38 Mitogen-Activated Protein Kinases | 3 | 2016 | 262 | 0.200 |
Why?
| Molecular Targeted Therapy | 2 | 2017 | 347 | 0.200 |
Why?
| Cocaine-Related Disorders | 1 | 2023 | 107 | 0.200 |
Why?
| Caspase 1 | 3 | 2020 | 140 | 0.200 |
Why?
| Social Behavior | 8 | 2018 | 268 | 0.200 |
Why?
| Psychoneuroimmunology | 3 | 2002 | 11 | 0.190 |
Why?
| Fentanyl | 2 | 2019 | 66 | 0.190 |
Why?
| GABA Antagonists | 4 | 2010 | 32 | 0.190 |
Why?
| Spinal Nerve Roots | 2 | 2012 | 28 | 0.190 |
Why?
| Neurogenesis | 1 | 2022 | 102 | 0.190 |
Why?
| Cell Communication | 3 | 2009 | 279 | 0.190 |
Why?
| alpha7 Nicotinic Acetylcholine Receptor | 2 | 2012 | 96 | 0.180 |
Why?
| Tail | 11 | 2007 | 29 | 0.180 |
Why?
| Dexamethasone | 5 | 2012 | 317 | 0.180 |
Why?
| Central Nervous System Depressants | 2 | 2014 | 82 | 0.180 |
Why?
| Zymosan | 4 | 2005 | 63 | 0.180 |
Why?
| Models, Molecular | 5 | 2012 | 1378 | 0.180 |
Why?
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 4 | 2009 | 9 | 0.180 |
Why?
| Receptors, HIV | 3 | 2004 | 23 | 0.180 |
Why?
| Touch | 3 | 2013 | 30 | 0.180 |
Why?
| Drug Interactions | 6 | 2008 | 340 | 0.180 |
Why?
| Receptors, Cytokine | 3 | 2004 | 33 | 0.180 |
Why?
| Thoracic Vertebrae | 2 | 2019 | 68 | 0.180 |
Why?
| Dogs | 2 | 2020 | 334 | 0.180 |
Why?
| Drug Synergism | 4 | 2015 | 316 | 0.180 |
Why?
| Convulsants | 4 | 1998 | 6 | 0.170 |
Why?
| Mice, Inbred C57BL | 4 | 2021 | 4710 | 0.170 |
Why?
| Specific Pathogen-Free Organisms | 5 | 2004 | 59 | 0.170 |
Why?
| AIDS Dementia Complex | 1 | 2000 | 50 | 0.170 |
Why?
| Body Temperature | 4 | 2001 | 208 | 0.170 |
Why?
| Carbolines | 4 | 1998 | 27 | 0.170 |
Why?
| Thalamus | 2 | 2018 | 74 | 0.170 |
Why?
| Lithium Chloride | 3 | 1994 | 11 | 0.170 |
Why?
| Lovastatin | 1 | 2019 | 26 | 0.170 |
Why?
| Pituitary-Adrenal System | 5 | 2004 | 131 | 0.160 |
Why?
| Diaphragm | 5 | 2001 | 31 | 0.160 |
Why?
| Microfilament Proteins | 3 | 2016 | 127 | 0.160 |
Why?
| CLOCK Proteins | 1 | 2018 | 8 | 0.160 |
Why?
| Tumor Necrosis Factor Decoy Receptors | 3 | 2004 | 7 | 0.160 |
Why?
| Purinergic P1 Receptor Agonists | 1 | 2018 | 8 | 0.160 |
Why?
| Somatosensory Cortex | 2 | 2009 | 32 | 0.160 |
Why?
| Receptors, Purinergic P1 | 1 | 2018 | 23 | 0.160 |
Why?
| Motor Disorders | 1 | 2018 | 16 | 0.160 |
Why?
| Biomarkers | 5 | 2012 | 3414 | 0.160 |
Why?
| Abdomen | 1 | 1999 | 100 | 0.160 |
Why?
| Calcium-Binding Proteins | 3 | 2016 | 207 | 0.160 |
Why?
| Immunization | 4 | 2018 | 401 | 0.160 |
Why?
| Medulla Oblongata | 2 | 2014 | 33 | 0.160 |
Why?
| Maze Learning | 2 | 2016 | 86 | 0.150 |
Why?
| Methadone | 2 | 2010 | 77 | 0.150 |
Why?
| Receptor, Serotonin, 5-HT1A | 2 | 2011 | 39 | 0.150 |
Why?
| Septal Nuclei | 2 | 2011 | 16 | 0.150 |
Why?
| Sleep Disorders, Circadian Rhythm | 1 | 2018 | 37 | 0.150 |
Why?
| Molecular Docking Simulation | 2 | 2018 | 101 | 0.150 |
Why?
| Gene Knockdown Techniques | 1 | 2019 | 299 | 0.150 |
Why?
| Designer Drugs | 1 | 2018 | 8 | 0.150 |
Why?
| Body Weight | 4 | 2018 | 869 | 0.150 |
Why?
| Hemocyanins | 7 | 2003 | 55 | 0.150 |
Why?
| Receptors, Corticotropin-Releasing Hormone | 3 | 2004 | 32 | 0.150 |
Why?
| Bacterial Vaccines | 1 | 2018 | 61 | 0.150 |
Why?
| Probiotics | 1 | 2018 | 46 | 0.150 |
Why?
| Brain Injuries | 2 | 2013 | 452 | 0.150 |
Why?
| Cyclooxygenase 1 | 2 | 2008 | 20 | 0.150 |
Why?
| Transcortin | 4 | 1999 | 14 | 0.150 |
Why?
| Statistics, Nonparametric | 1 | 2018 | 386 | 0.150 |
Why?
| Excitatory Amino Acid Antagonists | 1 | 2018 | 87 | 0.150 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 386 | 0.150 |
Why?
| Receptors, Purinergic P2X7 | 1 | 2017 | 11 | 0.150 |
Why?
| Muscimol | 7 | 2011 | 19 | 0.150 |
Why?
| Amphetamine | 3 | 2010 | 22 | 0.150 |
Why?
| Recombinant Proteins | 7 | 2005 | 1233 | 0.140 |
Why?
| Taste | 3 | 2008 | 209 | 0.140 |
Why?
| Nitrites | 2 | 2016 | 74 | 0.140 |
Why?
| Acoustic Stimulation | 5 | 2011 | 315 | 0.140 |
Why?
| Facial Nucleus | 1 | 2016 | 1 | 0.140 |
Why?
| Restraint, Physical | 10 | 2007 | 67 | 0.140 |
Why?
| Macrophage Activation | 1 | 2018 | 164 | 0.140 |
Why?
| Dura Mater | 1 | 2017 | 27 | 0.140 |
Why?
| Rats, Inbred Strains | 7 | 2017 | 354 | 0.140 |
Why?
| Models, Biological | 3 | 2017 | 1630 | 0.140 |
Why?
| Toll-Like Receptor 5 | 1 | 2016 | 14 | 0.140 |
Why?
| Activating Transcription Factor 3 | 1 | 2016 | 4 | 0.140 |
Why?
| Receptors, Purinergic P2X5 | 1 | 2016 | 4 | 0.140 |
Why?
| Arrhythmias, Cardiac | 2 | 2018 | 278 | 0.140 |
Why?
| Spatial Memory | 1 | 2016 | 17 | 0.140 |
Why?
| Habenula | 1 | 2016 | 11 | 0.140 |
Why?
| p21-Activated Kinases | 1 | 2016 | 14 | 0.140 |
Why?
| Brain Ischemia | 2 | 2018 | 299 | 0.140 |
Why?
| Down-Regulation | 2 | 2017 | 596 | 0.140 |
Why?
| CX3C Chemokine Receptor 1 | 3 | 2004 | 17 | 0.140 |
Why?
| Radiculopathy | 2 | 2014 | 27 | 0.130 |
Why?
| Neurogenic Inflammation | 1 | 2016 | 2 | 0.130 |
Why?
| Hydrazones | 3 | 2003 | 21 | 0.130 |
Why?
| Genetic Vectors | 3 | 2009 | 291 | 0.130 |
Why?
| Cell Count | 9 | 2009 | 305 | 0.130 |
Why?
| Life Expectancy | 1 | 2016 | 51 | 0.130 |
Why?
| Antibodies, Neutralizing | 1 | 2018 | 221 | 0.130 |
Why?
| Analgesics, Non-Narcotic | 1 | 1997 | 117 | 0.130 |
Why?
| Flumazenil | 1 | 1995 | 6 | 0.130 |
Why?
| Physical Conditioning, Animal | 3 | 2014 | 194 | 0.130 |
Why?
| Nociception | 2 | 2015 | 17 | 0.130 |
Why?
| Autoimmunity | 1 | 2021 | 814 | 0.130 |
Why?
| Isomerism | 2 | 2018 | 43 | 0.130 |
Why?
| Polyethylene Glycols | 2 | 2010 | 561 | 0.120 |
Why?
| Reflex, Abnormal | 1 | 2014 | 7 | 0.120 |
Why?
| Body Temperature Regulation | 2 | 2009 | 72 | 0.120 |
Why?
| NG-Nitroarginine Methyl Ester | 2 | 2005 | 38 | 0.120 |
Why?
| Excitatory Amino Acids | 1 | 1994 | 7 | 0.120 |
Why?
| Picrotoxin | 5 | 2018 | 12 | 0.120 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 40 | 0.120 |
Why?
| Receptors, GABA-A | 1 | 1995 | 82 | 0.120 |
Why?
| Immunosuppressive Agents | 2 | 2013 | 647 | 0.120 |
Why?
| Drug Administration Routes | 2 | 2012 | 40 | 0.120 |
Why?
| Mice, Inbred C3H | 1 | 2015 | 241 | 0.120 |
Why?
| Neuropeptides | 1 | 1994 | 65 | 0.120 |
Why?
| Antibody Formation | 5 | 1998 | 267 | 0.120 |
Why?
| Circadian Clocks | 1 | 2014 | 42 | 0.120 |
Why?
| Host-Pathogen Interactions | 3 | 2012 | 295 | 0.120 |
Why?
| Morphine Dependence | 2 | 2011 | 2 | 0.120 |
Why?
| Memory, Long-Term | 3 | 2020 | 11 | 0.120 |
Why?
| Escherichia coli | 5 | 2016 | 722 | 0.110 |
Why?
| Thiazolidinediones | 1 | 2015 | 142 | 0.110 |
Why?
| Nervous System | 1 | 1994 | 63 | 0.110 |
Why?
| Glucose | 1 | 2019 | 897 | 0.110 |
Why?
| Leukocytes, Mononuclear | 1 | 2016 | 493 | 0.110 |
Why?
| B-Lymphocytes | 2 | 2012 | 769 | 0.110 |
Why?
| PPAR gamma | 1 | 2015 | 182 | 0.110 |
Why?
| Phosphorylation | 3 | 2012 | 1571 | 0.110 |
Why?
| Brain Stem | 2 | 2010 | 101 | 0.110 |
Why?
| Phosphodiesterase Inhibitors | 1 | 2014 | 82 | 0.110 |
Why?
| Cell Death | 1 | 2015 | 322 | 0.110 |
Why?
| Recovery of Function | 1 | 2017 | 572 | 0.110 |
Why?
| Blood-Brain Barrier | 2 | 2009 | 106 | 0.110 |
Why?
| Running | 2 | 2017 | 207 | 0.110 |
Why?
| Interpersonal Relations | 1 | 2016 | 341 | 0.110 |
Why?
| Rats, Wistar | 4 | 2016 | 368 | 0.110 |
Why?
| Pentamidine | 1 | 2012 | 3 | 0.110 |
Why?
| Heroin | 1 | 2013 | 23 | 0.110 |
Why?
| Swimming | 1 | 2013 | 44 | 0.110 |
Why?
| Viral Matrix Proteins | 1 | 2012 | 24 | 0.100 |
Why?
| Interleukins | 2 | 2006 | 236 | 0.100 |
Why?
| Rifampin | 1 | 2013 | 68 | 0.100 |
Why?
| Serotonin Receptor Agonists | 4 | 2013 | 27 | 0.100 |
Why?
| Receptors, Cholecystokinin | 1 | 1992 | 5 | 0.100 |
Why?
| Oncogene Proteins v-fos | 4 | 2015 | 11 | 0.100 |
Why?
| Organ Culture Techniques | 2 | 2010 | 141 | 0.100 |
Why?
| Lipopeptides | 1 | 2012 | 14 | 0.100 |
Why?
| Pyrazoles | 1 | 1995 | 364 | 0.100 |
Why?
| Structure-Activity Relationship | 3 | 2019 | 503 | 0.100 |
Why?
| Somatostatin | 1 | 1992 | 52 | 0.100 |
Why?
| Cerebral Ventricles | 1 | 1992 | 47 | 0.100 |
Why?
| Cytoskeletal Proteins | 2 | 2010 | 145 | 0.100 |
Why?
| Tetracyclines | 1 | 2012 | 5 | 0.100 |
Why?
| DNA, Complementary | 2 | 2010 | 257 | 0.100 |
Why?
| Behavior, Addictive | 1 | 2013 | 81 | 0.100 |
Why?
| Association Learning | 4 | 2007 | 60 | 0.100 |
Why?
| Gene Transfer Techniques | 2 | 2010 | 147 | 0.100 |
Why?
| Antigens | 3 | 2003 | 318 | 0.100 |
Why?
| Cell Line, Transformed | 1 | 2012 | 133 | 0.100 |
Why?
| Herpesvirus 4, Human | 1 | 2012 | 125 | 0.100 |
Why?
| Tissue Distribution | 2 | 2016 | 285 | 0.100 |
Why?
| Lipopolysaccharide Receptors | 1 | 2012 | 82 | 0.100 |
Why?
| Phenylurea Compounds | 1 | 1992 | 84 | 0.100 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 164 | 0.100 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 368 | 0.100 |
Why?
| Stroke | 2 | 2018 | 1019 | 0.100 |
Why?
| Vasodilation | 1 | 2014 | 415 | 0.100 |
Why?
| DNA Primers | 2 | 2010 | 514 | 0.100 |
Why?
| Mice, Inbred CBA | 1 | 2011 | 53 | 0.090 |
Why?
| Heart Arrest | 1 | 2015 | 289 | 0.090 |
Why?
| Macrophages, Peritoneal | 1 | 2011 | 91 | 0.090 |
Why?
| Mitochondria | 1 | 2016 | 751 | 0.090 |
Why?
| Sensation | 1 | 1991 | 44 | 0.090 |
Why?
| Computational Biology | 2 | 2012 | 530 | 0.090 |
Why?
| Superoxides | 2 | 2022 | 214 | 0.090 |
Why?
| Peptide Fragments | 3 | 2011 | 668 | 0.090 |
Why?
| Hypnotics and Sedatives | 1 | 2012 | 134 | 0.090 |
Why?
| Rats, Inbred BN | 4 | 2012 | 52 | 0.090 |
Why?
| Adrenocorticotropic Hormone | 5 | 2004 | 129 | 0.090 |
Why?
| Endocrine Glands | 1 | 1990 | 16 | 0.090 |
Why?
| Neoplasms | 2 | 2010 | 2105 | 0.090 |
Why?
| Phenylephrine | 1 | 1990 | 71 | 0.090 |
Why?
| Drug Combinations | 2 | 2009 | 286 | 0.090 |
Why?
| GABA Agonists | 4 | 2008 | 14 | 0.090 |
Why?
| Food Preferences | 2 | 2008 | 108 | 0.090 |
Why?
| Sphingolipids | 1 | 2010 | 57 | 0.090 |
Why?
| Prostaglandins | 2 | 2007 | 78 | 0.090 |
Why?
| Benzylidene Compounds | 1 | 2010 | 17 | 0.090 |
Why?
| Muscles | 1 | 1991 | 320 | 0.090 |
Why?
| Immunologic Factors | 1 | 2012 | 220 | 0.090 |
Why?
| Anti-Infective Agents | 1 | 2012 | 225 | 0.090 |
Why?
| Perception | 1 | 1992 | 311 | 0.090 |
Why?
| Receptor, Serotonin, 5-HT2C | 1 | 2009 | 14 | 0.090 |
Why?
| Receptors, Interleukin-1 Type I | 2 | 2011 | 22 | 0.090 |
Why?
| Protein Interaction Mapping | 1 | 2010 | 101 | 0.090 |
Why?
| Motor Neurons | 1 | 2012 | 212 | 0.080 |
Why?
| Stress Disorders, Traumatic | 1 | 2009 | 23 | 0.080 |
Why?
| Bradykinin | 1 | 2009 | 43 | 0.080 |
Why?
| Eating | 3 | 2000 | 345 | 0.080 |
Why?
| Histamine | 1 | 2009 | 63 | 0.080 |
Why?
| Afferent Pathways | 3 | 2005 | 42 | 0.080 |
Why?
| Dimethyl Sulfoxide | 1 | 2009 | 43 | 0.080 |
Why?
| Infusion Pumps | 1 | 2009 | 31 | 0.080 |
Why?
| Antigens, Differentiation, Myelomonocytic | 1 | 2009 | 54 | 0.080 |
Why?
| Toll-Like Receptor 9 | 1 | 2009 | 30 | 0.080 |
Why?
| Amnesia, Retrograde | 2 | 2006 | 3 | 0.080 |
Why?
| Injections, Intravenous | 3 | 1998 | 201 | 0.080 |
Why?
| Immunoglobulin M | 4 | 2001 | 250 | 0.080 |
Why?
| Lactams, Macrocyclic | 1 | 2009 | 46 | 0.080 |
Why?
| Benzoquinones | 1 | 2009 | 44 | 0.080 |
Why?
| CpG Islands | 1 | 2009 | 117 | 0.080 |
Why?
| Anxiety Disorders | 1 | 2012 | 303 | 0.080 |
Why?
| Central Nervous System Infections | 1 | 2009 | 36 | 0.080 |
Why?
| High-Throughput Screening Assays | 1 | 2010 | 123 | 0.080 |
Why?
| Disease Susceptibility | 1 | 2011 | 316 | 0.080 |
Why?
| Sex Factors | 2 | 2012 | 1717 | 0.080 |
Why?
| Age Factors | 7 | 2010 | 2889 | 0.080 |
Why?
| Transgenes | 1 | 2009 | 170 | 0.080 |
Why?
| Spatial Behavior | 1 | 2008 | 20 | 0.080 |
Why?
| Cognition Disorders | 1 | 2012 | 476 | 0.080 |
Why?
| RAW 264.7 Cells | 2 | 2019 | 41 | 0.080 |
Why?
| Ligands | 1 | 2010 | 564 | 0.080 |
Why?
| Mental Disorders | 1 | 2016 | 889 | 0.080 |
Why?
| Safety | 3 | 2008 | 297 | 0.070 |
Why?
| Hypoglycemic Agents | 1 | 2015 | 1008 | 0.070 |
Why?
| beta-Adrenergic Receptor Kinases | 1 | 2007 | 6 | 0.070 |
Why?
| Immune Tolerance | 1 | 2009 | 328 | 0.070 |
Why?
| Mice, Transgenic | 1 | 2012 | 1951 | 0.070 |
Why?
| RNA, Antisense | 1 | 2007 | 17 | 0.070 |
Why?
| Drugs, Investigational | 1 | 2007 | 30 | 0.070 |
Why?
| Mutation | 2 | 2015 | 3349 | 0.070 |
Why?
| Foreign-Body Reaction | 1 | 2007 | 22 | 0.070 |
Why?
| Cholesterol | 2 | 2003 | 368 | 0.070 |
Why?
| Transcriptome | 1 | 2012 | 727 | 0.070 |
Why?
| Postoperative Complications | 2 | 2012 | 2127 | 0.070 |
Why?
| Oxidative Stress | 1 | 2013 | 1084 | 0.070 |
Why?
| GABA-A Receptor Agonists | 3 | 2011 | 9 | 0.070 |
Why?
| Receptors, Serotonin | 2 | 1997 | 32 | 0.070 |
Why?
| Stereoisomerism | 2 | 2019 | 91 | 0.070 |
Why?
| Evidence-Based Medicine | 1 | 2010 | 667 | 0.070 |
Why?
| Peptides | 2 | 2009 | 848 | 0.070 |
Why?
| Injections, Intramuscular | 1 | 2006 | 117 | 0.070 |
Why?
| Genes, MHC Class II | 1 | 2006 | 70 | 0.070 |
Why?
| Enzyme Activation | 2 | 2005 | 787 | 0.060 |
Why?
| Antibodies, Blocking | 1 | 2005 | 32 | 0.060 |
Why?
| Sodium Chloride | 1 | 2006 | 136 | 0.060 |
Why?
| Electric Stimulation | 4 | 2011 | 252 | 0.060 |
Why?
| Centrifugation | 1 | 2005 | 31 | 0.060 |
Why?
| Histocompatibility Antigens | 1 | 2006 | 100 | 0.060 |
Why?
| Epilepsy | 1 | 2009 | 277 | 0.060 |
Why?
| Cell Survival | 3 | 2019 | 1021 | 0.060 |
Why?
| Caspase Inhibitors | 1 | 2005 | 78 | 0.060 |
Why?
| Computer Simulation | 1 | 2009 | 878 | 0.060 |
Why?
| Reinforcement Schedule | 3 | 2017 | 29 | 0.060 |
Why?
| Blotting, Western | 3 | 2013 | 1151 | 0.060 |
Why?
| Clinical Trials as Topic | 1 | 2009 | 934 | 0.060 |
Why?
| Complement C5a | 1 | 2005 | 59 | 0.060 |
Why?
| Adrenal Glands | 2 | 2018 | 67 | 0.060 |
Why?
| Hormone Antagonists | 3 | 2016 | 33 | 0.060 |
Why?
| Complement C3a | 1 | 2005 | 33 | 0.060 |
Why?
| Stress, Mechanical | 1 | 2007 | 445 | 0.060 |
Why?
| Adult | 4 | 2022 | 30543 | 0.060 |
Why?
| Carbenoxolone | 1 | 2004 | 2 | 0.060 |
Why?
| Electric Countershock | 2 | 1984 | 104 | 0.060 |
Why?
| Glycyrrhizic Acid | 1 | 2004 | 3 | 0.060 |
Why?
| Anti-Ulcer Agents | 1 | 2004 | 16 | 0.060 |
Why?
| In Vitro Techniques | 1 | 2006 | 1013 | 0.060 |
Why?
| Nerve Compression Syndromes | 1 | 2004 | 25 | 0.060 |
Why?
| Nitric Oxide Synthase Type I | 1 | 2004 | 25 | 0.060 |
Why?
| Cell Separation | 1 | 2005 | 292 | 0.060 |
Why?
| Adenoviridae | 1 | 2005 | 185 | 0.060 |
Why?
| Receptors, Adrenergic, alpha-1 | 1 | 2004 | 41 | 0.060 |
Why?
| Catalase | 1 | 2004 | 117 | 0.060 |
Why?
| N-Methylaspartate | 1 | 2004 | 37 | 0.060 |
Why?
| Binding Sites | 2 | 2018 | 1176 | 0.060 |
Why?
| Hypothermia | 1 | 2004 | 38 | 0.060 |
Why?
| Mental Recall | 2 | 1995 | 170 | 0.060 |
Why?
| Sample Size | 1 | 2004 | 114 | 0.060 |
Why?
| Peripheral Nervous System | 1 | 2003 | 17 | 0.060 |
Why?
| Receptors, Opioid, kappa | 2 | 1994 | 11 | 0.060 |
Why?
| Histocompatibility Antigens Class II | 2 | 2010 | 353 | 0.060 |
Why?
| Chromatography, High Pressure Liquid | 4 | 2009 | 472 | 0.060 |
Why?
| Complement Membrane Attack Complex | 1 | 2023 | 33 | 0.060 |
Why?
| Lymph Nodes | 3 | 2001 | 423 | 0.060 |
Why?
| Aconitate Hydratase | 1 | 2003 | 16 | 0.050 |
Why?
| Cell Culture Techniques | 1 | 2005 | 343 | 0.050 |
Why?
| Pressure | 1 | 2004 | 218 | 0.050 |
Why?
| Neck | 2 | 2001 | 83 | 0.050 |
Why?
| Social Isolation | 1 | 2003 | 52 | 0.050 |
Why?
| Receptors, Cell Surface | 1 | 2004 | 354 | 0.050 |
Why?
| Psychomotor Performance | 3 | 2015 | 280 | 0.050 |
Why?
| Immobility Response, Tonic | 2 | 2013 | 4 | 0.050 |
Why?
| Peripheral Nerves | 1 | 2003 | 64 | 0.050 |
Why?
| Reflex | 2 | 1994 | 64 | 0.050 |
Why?
| Superoxide Dismutase | 1 | 2004 | 305 | 0.050 |
Why?
| Antioxidants | 2 | 2022 | 530 | 0.050 |
Why?
| Peroxynitrous Acid | 1 | 2022 | 11 | 0.050 |
Why?
| Myelin Sheath | 1 | 2023 | 144 | 0.050 |
Why?
| Lumbar Vertebrae | 1 | 2004 | 209 | 0.050 |
Why?
| Reproducibility of Results | 2 | 2012 | 2762 | 0.050 |
Why?
| NADPH Oxidase 2 | 1 | 2022 | 42 | 0.050 |
Why?
| Death, Sudden | 1 | 1982 | 27 | 0.050 |
Why?
| Nodose Ganglion | 2 | 1998 | 6 | 0.050 |
Why?
| Stem Cells | 1 | 2006 | 546 | 0.050 |
Why?
| T-Lymphocyte Subsets | 2 | 1995 | 384 | 0.050 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 316 | 0.050 |
Why?
| Evoked Potentials, Auditory | 2 | 2011 | 172 | 0.050 |
Why?
| Depression | 2 | 2008 | 1133 | 0.050 |
Why?
| Ventricular Fibrillation | 1 | 1982 | 51 | 0.050 |
Why?
| Interferon-gamma | 4 | 2001 | 722 | 0.050 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2003 | 278 | 0.050 |
Why?
| Acute Disease | 2 | 2001 | 912 | 0.050 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2022 | 157 | 0.050 |
Why?
| NF-E2-Related Factor 2 | 1 | 2022 | 71 | 0.050 |
Why?
| Protein Conformation | 2 | 2018 | 811 | 0.050 |
Why?
| Alzheimer Disease | 2 | 2020 | 436 | 0.050 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 2012 | 319 | 0.050 |
Why?
| Hydrocortisone | 4 | 2009 | 269 | 0.050 |
Why?
| Aminopyridines | 2 | 2013 | 81 | 0.050 |
Why?
| Injections | 2 | 2013 | 159 | 0.050 |
Why?
| Organ Size | 1 | 2001 | 435 | 0.050 |
Why?
| Phosphate-Binding Proteins | 1 | 2020 | 5 | 0.050 |
Why?
| Immunoglobulin G | 3 | 2001 | 774 | 0.050 |
Why?
| Rodentia | 1 | 2020 | 44 | 0.040 |
Why?
| Evoked Potentials, Somatosensory | 2 | 2011 | 31 | 0.040 |
Why?
| Crisis Intervention | 1 | 2020 | 29 | 0.040 |
Why?
| Anti-Bacterial Agents | 2 | 2008 | 1477 | 0.040 |
Why?
| Adjuvants, Immunologic | 2 | 2003 | 206 | 0.040 |
Why?
| Amino Acid Sequence | 2 | 2016 | 1988 | 0.040 |
Why?
| Peritoneum | 1 | 2000 | 36 | 0.040 |
Why?
| Receptors, Mineralocorticoid | 1 | 1999 | 7 | 0.040 |
Why?
| Pyrimidines | 2 | 2003 | 378 | 0.040 |
Why?
| Therapeutic Irrigation | 1 | 2000 | 67 | 0.040 |
Why?
| Subarachnoid Space | 1 | 1999 | 8 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2004 | 1690 | 0.040 |
Why?
| Urocortins | 3 | 2004 | 19 | 0.040 |
Why?
| Paresis | 1 | 1999 | 28 | 0.040 |
Why?
| Coronary Disease | 1 | 1982 | 347 | 0.040 |
Why?
| Opioid Peptides | 1 | 1999 | 4 | 0.040 |
Why?
| Motor Skills Disorders | 1 | 1999 | 23 | 0.040 |
Why?
| Fluorescent Dyes | 2 | 2012 | 300 | 0.040 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2005 | 452 | 0.040 |
Why?
| RNA, Double-Stranded | 1 | 2019 | 44 | 0.040 |
Why?
| Immunity | 1 | 2000 | 121 | 0.040 |
Why?
| alpha-MSH | 1 | 1998 | 5 | 0.040 |
Why?
| Primary Cell Culture | 1 | 2019 | 149 | 0.040 |
Why?
| Cerebellum | 1 | 2000 | 200 | 0.040 |
Why?
| Acute-Phase Reaction | 1 | 1998 | 39 | 0.040 |
Why?
| Glossopharyngeal Nerve | 1 | 1998 | 11 | 0.040 |
Why?
| Immunologic Deficiency Syndromes | 2 | 2001 | 61 | 0.040 |
Why?
| Optical Fibers | 1 | 2018 | 18 | 0.040 |
Why?
| Cell Proliferation | 3 | 2012 | 2196 | 0.040 |
Why?
| Memory, Short-Term | 1 | 2020 | 223 | 0.040 |
Why?
| Injections, Epidural | 1 | 1998 | 18 | 0.040 |
Why?
| Limbic Lobe | 1 | 2018 | 2 | 0.040 |
Why?
| Protein Structure, Secondary | 1 | 2019 | 325 | 0.040 |
Why?
| Neuroanatomical Tract-Tracing Techniques | 1 | 2018 | 5 | 0.040 |
Why?
| Stilbamidines | 1 | 2018 | 10 | 0.040 |
Why?
| Fluorescent Antibody Technique | 1 | 1999 | 396 | 0.040 |
Why?
| Vaccines, Inactivated | 1 | 2018 | 68 | 0.040 |
Why?
| Administration, Intranasal | 1 | 2018 | 75 | 0.040 |
Why?
| Bromodeoxyuridine | 2 | 2009 | 72 | 0.040 |
Why?
| Sucrose | 2 | 2008 | 91 | 0.040 |
Why?
| Immunoassay | 1 | 2018 | 95 | 0.040 |
Why?
| Pyrroles | 1 | 1999 | 183 | 0.040 |
Why?
| Receptors, GABA | 1 | 1997 | 8 | 0.040 |
Why?
| Isonicotinic Acids | 1 | 1997 | 1 | 0.040 |
Why?
| Amnesia, Anterograde | 2 | 2008 | 3 | 0.040 |
Why?
| Thermosensing | 2 | 1997 | 10 | 0.040 |
Why?
| Baclofen | 1 | 1997 | 10 | 0.040 |
Why?
| Oxytocics | 1 | 1997 | 15 | 0.040 |
Why?
| Biguanides | 1 | 1997 | 12 | 0.040 |
Why?
| Mannose | 1 | 2017 | 21 | 0.040 |
Why?
| Analgesia, Epidural | 1 | 1997 | 20 | 0.040 |
Why?
| Skin Temperature | 2 | 1994 | 16 | 0.040 |
Why?
| Nerve Net | 1 | 2000 | 225 | 0.040 |
Why?
| RNA, Small Interfering | 1 | 2019 | 543 | 0.040 |
Why?
| Histocytochemistry | 1 | 1997 | 79 | 0.030 |
Why?
| Transcriptional Activation | 1 | 1999 | 337 | 0.030 |
Why?
| Basolateral Nuclear Complex | 1 | 2016 | 11 | 0.030 |
Why?
| Phosphopyruvate Hydratase | 2 | 2007 | 30 | 0.030 |
Why?
| Drug Evaluation, Preclinical | 1 | 1997 | 165 | 0.030 |
Why?
| Period Circadian Proteins | 1 | 2016 | 12 | 0.030 |
Why?
| Extracellular Space | 2 | 2009 | 117 | 0.030 |
Why?
| Jurkat Cells | 1 | 2016 | 128 | 0.030 |
Why?
| Epinephrine | 2 | 1994 | 164 | 0.030 |
Why?
| Immunoglobulins | 1 | 1996 | 143 | 0.030 |
Why?
| Psychological Tests | 1 | 2016 | 120 | 0.030 |
Why?
| Receptors, Adrenergic, beta | 1 | 1996 | 124 | 0.030 |
Why?
| Anesthetics, Dissociative | 1 | 2016 | 28 | 0.030 |
Why?
| Hypercholesterolemia | 1 | 1996 | 90 | 0.030 |
Why?
| Dentate Gyrus | 2 | 2006 | 30 | 0.030 |
Why?
| Leukocytes | 2 | 2011 | 277 | 0.030 |
Why?
| Dysgammaglobulinemia | 1 | 1995 | 2 | 0.030 |
Why?
| IgG Deficiency | 1 | 1995 | 8 | 0.030 |
Why?
| Optogenetics | 1 | 2016 | 95 | 0.030 |
Why?
| Staphylococcal Infections | 1 | 1999 | 336 | 0.030 |
Why?
| Weight Gain | 1 | 2018 | 452 | 0.030 |
Why?
| Saccharin | 1 | 1995 | 4 | 0.030 |
Why?
| Animal Diseases | 1 | 2015 | 5 | 0.030 |
Why?
| Leukocyte Common Antigens | 1 | 1995 | 76 | 0.030 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2014 | 5 | 0.030 |
Why?
| Lymphocyte Culture Test, Mixed | 1 | 1995 | 42 | 0.030 |
Why?
| Capsaicin | 1 | 2015 | 26 | 0.030 |
Why?
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1994 | 4 | 0.030 |
Why?
| Chlorisondamine | 1 | 1994 | 4 | 0.030 |
Why?
| Adrenal Medulla | 1 | 1994 | 7 | 0.030 |
Why?
| CD4 Antigens | 1 | 1995 | 124 | 0.030 |
Why?
| Treatment Outcome | 3 | 2016 | 9089 | 0.030 |
Why?
| Blood Proteins | 1 | 1997 | 232 | 0.030 |
Why?
| Monitoring, Physiologic | 2 | 1990 | 248 | 0.030 |
Why?
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2014 | 4 | 0.030 |
Why?
| In Situ Hybridization | 2 | 2005 | 293 | 0.030 |
Why?
| Substance P | 1 | 1994 | 44 | 0.030 |
Why?
| Biphenyl Compounds | 1 | 1994 | 50 | 0.030 |
Why?
| Pregnancy | 3 | 2017 | 5525 | 0.030 |
Why?
| Monocytes | 1 | 1997 | 503 | 0.030 |
Why?
| Ganglionectomy | 1 | 1994 | 1 | 0.030 |
Why?
| Kupffer Cells | 1 | 1994 | 45 | 0.030 |
Why?
| Decerebrate State | 1 | 1994 | 4 | 0.030 |
Why?
| Weight Loss | 2 | 2009 | 642 | 0.030 |
Why?
| Area Under Curve | 1 | 2015 | 275 | 0.030 |
Why?
| Auditory Cortex | 1 | 1994 | 41 | 0.030 |
Why?
| Ganglia, Sympathetic | 1 | 1994 | 18 | 0.030 |
Why?
| Antidepressive Agents | 1 | 2016 | 194 | 0.030 |
Why?
| Adiposity | 1 | 2018 | 457 | 0.030 |
Why?
| Valine | 1 | 2014 | 72 | 0.030 |
Why?
| Basal Ganglia | 1 | 1994 | 42 | 0.030 |
Why?
| Catalysis | 1 | 2014 | 292 | 0.030 |
Why?
| Biological Transport | 1 | 1995 | 372 | 0.030 |
Why?
| Respiration | 1 | 2014 | 179 | 0.030 |
Why?
| Anesthetics | 1 | 1993 | 54 | 0.030 |
Why?
| Infusion Pumps, Implantable | 1 | 2013 | 20 | 0.030 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 181 | 0.030 |
Why?
| Receptors, Opioid, delta | 1 | 1992 | 8 | 0.030 |
Why?
| Benzodiazepinones | 1 | 1992 | 14 | 0.030 |
Why?
| Receptors, IgE | 1 | 2012 | 40 | 0.030 |
Why?
| Oxidation-Reduction | 1 | 2015 | 927 | 0.030 |
Why?
| Cardiopulmonary Resuscitation | 1 | 2015 | 220 | 0.030 |
Why?
| Spodoptera | 1 | 2012 | 36 | 0.030 |
Why?
| Phosphatidylcholines | 1 | 2013 | 133 | 0.030 |
Why?
| MAP Kinase Kinase 4 | 1 | 2012 | 23 | 0.030 |
Why?
| Receptors, IgG | 1 | 2012 | 67 | 0.030 |
Why?
| NF-KappaB Inhibitor alpha | 1 | 2012 | 52 | 0.030 |
Why?
| Cell Differentiation | 1 | 2019 | 1699 | 0.020 |
Why?
| Biological Assay | 1 | 2012 | 113 | 0.020 |
Why?
| Virus Activation | 1 | 2012 | 78 | 0.020 |
Why?
| Gliosarcoma | 1 | 1992 | 8 | 0.020 |
Why?
| Lymphocyte Transfusion | 1 | 1992 | 19 | 0.020 |
Why?
| Calcitonin Gene-Related Peptide | 1 | 2012 | 31 | 0.020 |
Why?
| Biophysics | 1 | 2012 | 70 | 0.020 |
Why?
| Kinetics | 2 | 2006 | 1550 | 0.020 |
Why?
| Foot | 1 | 1992 | 103 | 0.020 |
Why?
| I-kappa B Proteins | 1 | 2012 | 78 | 0.020 |
Why?
| Dimerization | 1 | 2012 | 176 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 113 | 0.020 |
Why?
| Azoles | 1 | 2011 | 4 | 0.020 |
Why?
| Nitrobenzenes | 1 | 2011 | 13 | 0.020 |
Why?
| Tetrodotoxin | 1 | 2011 | 39 | 0.020 |
Why?
| Protein Multimerization | 1 | 2012 | 159 | 0.020 |
Why?
| T-Cell Antigen Receptor Specificity | 1 | 2011 | 41 | 0.020 |
Why?
| Biotin | 1 | 2011 | 20 | 0.020 |
Why?
| Physical Exertion | 1 | 1992 | 211 | 0.020 |
Why?
| Molecular Mimicry | 1 | 2011 | 35 | 0.020 |
Why?
| Statistics as Topic | 1 | 2012 | 294 | 0.020 |
Why?
| Pyramidal Tracts | 1 | 2011 | 20 | 0.020 |
Why?
| Rotarod Performance Test | 1 | 2011 | 17 | 0.020 |
Why?
| Reflex, Righting | 1 | 2011 | 10 | 0.020 |
Why?
| Dextrans | 1 | 2011 | 74 | 0.020 |
Why?
| Electrophysiology | 1 | 2011 | 201 | 0.020 |
Why?
| Spectrometry, Fluorescence | 1 | 2011 | 157 | 0.020 |
Why?
| Arginine Vasopressin | 1 | 1990 | 46 | 0.020 |
Why?
| Sphingosine | 1 | 2010 | 33 | 0.020 |
Why?
| Interleukin-2 | 1 | 1992 | 417 | 0.020 |
Why?
| Vasopressins | 1 | 1990 | 56 | 0.020 |
Why?
| Lysophospholipids | 1 | 2010 | 65 | 0.020 |
Why?
| RNA Interference | 1 | 2012 | 437 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2012 | 797 | 0.020 |
Why?
| Polyglycolic Acid | 1 | 2010 | 43 | 0.020 |
Why?
| Vaccination | 1 | 2018 | 1205 | 0.020 |
Why?
| PC12 Cells | 1 | 2009 | 37 | 0.020 |
Why?
| Immunotherapy, Adoptive | 1 | 1992 | 184 | 0.020 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 138 | 0.020 |
Why?
| Serotonin Antagonists | 1 | 2009 | 30 | 0.020 |
Why?
| Dominance-Subordination | 1 | 2009 | 15 | 0.020 |
Why?
| Antimetabolites | 1 | 2009 | 21 | 0.020 |
Why?
| Genes, fos | 1 | 2009 | 33 | 0.020 |
Why?
| Temperature | 1 | 1992 | 575 | 0.020 |
Why?
| Adaptation, Physiological | 2 | 2003 | 483 | 0.020 |
Why?
| Electromyography | 1 | 1991 | 326 | 0.020 |
Why?
| Esters | 1 | 2009 | 61 | 0.020 |
Why?
| Drinking | 2 | 1999 | 33 | 0.020 |
Why?
| Biological Products | 1 | 2012 | 167 | 0.020 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 1995 | 965 | 0.020 |
Why?
| Myelin-Associated Glycoprotein | 1 | 2008 | 5 | 0.020 |
Why?
| Particle Size | 1 | 2010 | 317 | 0.020 |
Why?
| Aldehydes | 1 | 2009 | 142 | 0.020 |
Why?
| Exercise Test | 1 | 2011 | 544 | 0.020 |
Why?
| Action Potentials | 1 | 2011 | 406 | 0.020 |
Why?
| Microscopy, Confocal | 1 | 2009 | 305 | 0.020 |
Why?
| Myelin Proteins | 1 | 2008 | 42 | 0.020 |
Why?
| Endothelium, Vascular | 1 | 1995 | 843 | 0.020 |
Why?
| GABA-A Receptor Antagonists | 1 | 2008 | 14 | 0.020 |
Why?
| Lactic Acid | 1 | 2010 | 275 | 0.020 |
Why?
| Parietal Lobe | 1 | 2008 | 41 | 0.020 |
Why?
| Sequence Analysis, DNA | 1 | 2011 | 728 | 0.020 |
Why?
| Chemical and Drug Induced Liver Injury | 1 | 2009 | 123 | 0.020 |
Why?
| Naproxen | 1 | 2007 | 11 | 0.020 |
Why?
| Anticonvulsants | 1 | 2009 | 178 | 0.020 |
Why?
| Immunologic Memory | 1 | 2009 | 313 | 0.020 |
Why?
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2007 | 11 | 0.020 |
Why?
| Bacterial Proteins | 1 | 2012 | 739 | 0.020 |
Why?
| Heart Rate | 1 | 1990 | 704 | 0.020 |
Why?
| Mesentery | 2 | 1998 | 53 | 0.020 |
Why?
| Endotoxemia | 1 | 2007 | 82 | 0.020 |
Why?
| Bronchodilator Agents | 1 | 2008 | 240 | 0.020 |
Why?
| Gyrus Cinguli | 1 | 2006 | 70 | 0.020 |
Why?
| Mass Spectrometry | 1 | 2009 | 633 | 0.020 |
Why?
| Molecular Sequence Data | 1 | 2011 | 2791 | 0.020 |
Why?
| Nanoparticles | 1 | 2010 | 313 | 0.020 |
Why?
| Phenotype | 2 | 2009 | 2811 | 0.020 |
Why?
| Thiocarbamates | 1 | 2005 | 6 | 0.020 |
Why?
| Microtubule-Associated Proteins | 1 | 2007 | 174 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2012 | 2725 | 0.020 |
Why?
| Sleep | 1 | 2011 | 632 | 0.020 |
Why?
| Estrous Cycle | 1 | 2005 | 14 | 0.020 |
Why?
| Locus Coeruleus | 1 | 2005 | 19 | 0.020 |
Why?
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2005 | 57 | 0.020 |
Why?
| Tyrosine 3-Monooxygenase | 1 | 2005 | 68 | 0.020 |
Why?
| Proline | 1 | 2005 | 72 | 0.020 |
Why?
| Image Processing, Computer-Assisted | 1 | 2009 | 683 | 0.020 |
Why?
| Motor Cortex | 1 | 2005 | 47 | 0.020 |
Why?
| HIV Infections | 1 | 1999 | 2469 | 0.020 |
Why?
| 5,7-Dihydroxytryptamine | 1 | 2004 | 3 | 0.020 |
Why?
| Pro-Opiomelanocortin | 1 | 2004 | 17 | 0.020 |
Why?
| Metyrapone | 1 | 2004 | 2 | 0.020 |
Why?
| Aminoglutethimide | 1 | 2004 | 6 | 0.020 |
Why?
| Serotonin Agents | 1 | 2004 | 8 | 0.020 |
Why?
| Reptilian Proteins | 1 | 2004 | 3 | 0.020 |
Why?
| Rats, Mutant Strains | 1 | 2004 | 25 | 0.020 |
Why?
| Transcription Factors | 1 | 2012 | 1528 | 0.020 |
Why?
| Receptors, Leptin | 1 | 2004 | 24 | 0.010 |
Why?
| Group II Phospholipases A2 | 1 | 2004 | 19 | 0.010 |
Why?
| Electrochemistry | 1 | 2004 | 79 | 0.010 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2004 | 72 | 0.010 |
Why?
| Sepsis | 1 | 2010 | 508 | 0.010 |
Why?
| Blood Pressure | 1 | 1990 | 1530 | 0.010 |
Why?
| Catecholamines | 1 | 2004 | 94 | 0.010 |
Why?
| Concanavalin A | 1 | 2003 | 75 | 0.010 |
Why?
| Brain Neoplasms | 1 | 1992 | 984 | 0.010 |
Why?
| Serotonin 5-HT1 Receptor Antagonists | 1 | 2003 | 2 | 0.010 |
Why?
| Cholesterol, VLDL | 1 | 2003 | 4 | 0.010 |
Why?
| Electrolysis | 1 | 2003 | 2 | 0.010 |
Why?
| Immobilization | 1 | 2003 | 42 | 0.010 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2011 | 1892 | 0.010 |
Why?
| Apoptosis | 1 | 2012 | 2369 | 0.010 |
Why?
| gamma-Aminobutyric Acid | 1 | 2004 | 144 | 0.010 |
Why?
| Cholesterol, HDL | 1 | 2003 | 184 | 0.010 |
Why?
| Aniline Compounds | 1 | 2003 | 70 | 0.010 |
Why?
| Drug Resistance | 1 | 2003 | 158 | 0.010 |
Why?
| Neuropsychological Tests | 1 | 2006 | 913 | 0.010 |
Why?
| Prostheses and Implants | 1 | 1984 | 138 | 0.010 |
Why?
| Physical Examination | 1 | 2003 | 220 | 0.010 |
Why?
| Emotions | 1 | 2006 | 472 | 0.010 |
Why?
| Cell Division | 1 | 2003 | 759 | 0.010 |
Why?
| Wallerian Degeneration | 1 | 2001 | 1 | 0.010 |
Why?
| Gelatin Sponge, Absorbable | 1 | 2001 | 5 | 0.010 |
Why?
| Tachycardia | 1 | 1982 | 50 | 0.010 |
Why?
| Cholesterol, LDL | 1 | 2003 | 307 | 0.010 |
Why?
| Epitopes | 1 | 2003 | 435 | 0.010 |
Why?
| Dopamine Uptake Inhibitors | 1 | 2002 | 54 | 0.010 |
Why?
| Muscle Denervation | 1 | 2001 | 9 | 0.010 |
Why?
| Lymphocyte Count | 1 | 2001 | 133 | 0.010 |
Why?
| Diagnostic Imaging | 1 | 2004 | 275 | 0.010 |
Why?
| Immunoglobulin Isotypes | 1 | 2001 | 32 | 0.010 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2006 | 799 | 0.010 |
Why?
| Pregnancy Complications, Infectious | 1 | 2005 | 288 | 0.010 |
Why?
| Luminescent Measurements | 1 | 2001 | 74 | 0.010 |
Why?
| Spironolactone | 1 | 2001 | 28 | 0.010 |
Why?
| Hypertrophy | 1 | 2001 | 109 | 0.010 |
Why?
| Thymus Gland | 1 | 2001 | 296 | 0.010 |
Why?
| Gene Expression Profiling | 1 | 2006 | 1521 | 0.010 |
Why?
| Prognosis | 1 | 2007 | 3334 | 0.010 |
Why?
| Periaqueductal Gray | 1 | 1999 | 15 | 0.010 |
Why?
| Peritoneal Cavity | 1 | 1998 | 23 | 0.010 |
Why?
| Administration, Oral | 1 | 2001 | 731 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2007 | 4420 | 0.010 |
Why?
| Rats, Long-Evans | 1 | 1998 | 98 | 0.010 |
Why?
| Hydroxyindoleacetic Acid | 1 | 1998 | 19 | 0.010 |
Why?
| CD4 Lymphocyte Count | 1 | 1998 | 257 | 0.010 |
Why?
| Flow Cytometry | 1 | 2001 | 1086 | 0.010 |
Why?
| Butoxamine | 1 | 1996 | 1 | 0.010 |
Why?
| Atenolol | 1 | 1996 | 6 | 0.010 |
Why?
| Propranolol | 1 | 1996 | 49 | 0.010 |
Why?
| Receptors, Adrenergic, beta-2 | 1 | 1996 | 39 | 0.010 |
Why?
| Receptors, Adrenergic, beta-1 | 1 | 1996 | 45 | 0.010 |
Why?
| Prospective Studies | 1 | 2007 | 6216 | 0.010 |
Why?
| Fatty Acids, Nonesterified | 1 | 1996 | 151 | 0.010 |
Why?
| Diazepam | 1 | 1995 | 25 | 0.010 |
Why?
| Anti-Anxiety Agents | 1 | 1995 | 42 | 0.010 |
Why?
| Adrenal Cortex Hormones | 1 | 1999 | 498 | 0.010 |
Why?
| Electrodes, Implanted | 1 | 1995 | 91 | 0.010 |
Why?
| Nylons | 1 | 1995 | 18 | 0.010 |
Why?
| Cytological Techniques | 1 | 1995 | 23 | 0.010 |
Why?
| Jugular Veins | 1 | 1994 | 37 | 0.010 |
Why?
| Horseradish Peroxidase | 1 | 1994 | 25 | 0.010 |
Why?
| Adrenergic beta-Antagonists | 1 | 1996 | 287 | 0.010 |
Why?
| Methoxyflurane | 1 | 1993 | 2 | 0.010 |
Why?
| Chloral Hydrate | 1 | 1993 | 3 | 0.010 |
Why?
| Halothane | 1 | 1993 | 5 | 0.010 |
Why?
| Xylazine | 1 | 1993 | 6 | 0.010 |
Why?
| Pentobarbital | 1 | 1993 | 16 | 0.010 |
Why?
| CD4-CD8 Ratio | 1 | 1992 | 19 | 0.010 |
Why?
| Cold Temperature | 1 | 1993 | 128 | 0.010 |
Why?
| Obesity | 1 | 2004 | 2513 | 0.010 |
Why?
| Cholesterol, Dietary | 1 | 1992 | 15 | 0.010 |
Why?
| Neoplasm Transplantation | 1 | 1992 | 232 | 0.010 |
Why?
| Lymphocyte Activation | 1 | 1995 | 1044 | 0.010 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 1992 | 155 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 1992 | 854 | 0.010 |
Why?
| Dietary Fats | 1 | 1992 | 287 | 0.010 |
Why?
| Actuarial Analysis | 1 | 1984 | 21 | 0.000 |
Why?
| Aged | 1 | 1982 | 19079 | 0.000 |
Why?
| Adolescent | 1 | 1982 | 17808 | 0.000 |
Why?
| Middle Aged | 1 | 1982 | 26746 | 0.000 |
Why?
| Recurrence | 1 | 1984 | 936 | 0.000 |
Why?
| Electrocardiography | 1 | 1984 | 562 | 0.000 |
Why?
|
|
Watkins's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|